AB Science Valuation
| AB Stock | EUR 0.82 0.04 5.13% |
Today, the entity appears to be overvalued. AB Science SA owns a latest Real Value of €0.73 per share. The recent price of the entity is €0.82. Our model approximates the value of AB Science SA from evaluating the entity fundamentals such as Operating Margin of (12.22) %, price to earning of (10.99) X, and Shares Owned By Institutions of 1.79 % as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AB Science's price fluctuation is dangerous at this time. Calculation of the real value of AB Science SA is based on 3 months time horizon. Increasing AB Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AB Science is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AB Science Stock. However, AB Science's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.82 | Real 0.73 | Hype 0.82 | Naive 0.8 |
The real value of AB Science Stock, also known as its intrinsic value, is the underlying worth of AB Science SA Company, which is reflected in its stock price. It is based on AB Science's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AB Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AB Science SA helps investors to forecast how AB Science stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AB Science more accurately as focusing exclusively on AB Science's fundamentals will not take into account other important factors: AB Science Total Value Analysis
AB Science SA is presently projected to have takeover price of 427.66 M with market capitalization of 314.67 M, debt of 14.44 M, and cash on hands of 0. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AB Science fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
427.66 M | 314.67 M | 14.44 M | 0 |
AB Science Investor Information
About 41.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.43. AB Science SA had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from AB Science's historical financial statements, AB Science SA is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.AB Science Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AB Science has an asset utilization ratio of 7.55 percent. This suggests that the Company is making €0.0755 for each dollar of assets. An increasing asset utilization means that AB Science SA is more efficient with each dollar of assets it utilizes for everyday operations.AB Science Ownership Allocation
AB Science SA secures a total of 46.86 Million outstanding shares. AB Science SA shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.AB Science Profitability Analysis
The company reported the revenue of 1.61 M. Net Loss for the year was (14.19 M) with profit before overhead, payroll, taxes, and interest of 1.5 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AB Science's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AB Science and how it compares across the competition.
About AB Science Valuation
The stock valuation mechanism determines AB Science's current worth on a weekly basis. Our valuation model uses a comparative analysis of AB Science. We calculate exposure to AB Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AB Science's related companies.AB Science S.A., a pharmaceutical company, engages in the discovery, development, and commercialization of protein kinase inhibitors for use in human and veterinary medicines. AB Science S.A. was founded in 2001 and is headquartered in Paris, France. AB SCIENCE operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. It employs 123 people.
8 Steps to conduct AB Science's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AB Science's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AB Science's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AB Science's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AB Science's revenue streams: Identify AB Science's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AB Science's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AB Science's growth potential: Evaluate AB Science's management, business model, and growth potential.
- Determine AB Science's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AB Science's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for AB Science Stock analysis
When running AB Science's price analysis, check to measure AB Science's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AB Science is operating at the current time. Most of AB Science's value examination focuses on studying past and present price action to predict the probability of AB Science's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AB Science's price. Additionally, you may evaluate how the addition of AB Science to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |